IPA had said many of the patent claims made by multinationals do not necessarily enhance the efficacy of previously known drugs.
The two companies agreed to form a joint venture by combining Novartis' over-the-counter division with GSK's consumer business to create a business with $10 billion in annual sales. GSK will hold a 63.5 per cent stake in the venture.
Consolidation is the prime mood of the Indian equity market at the moment.
'But India, increasingly, is not that far behind, which is a story I never expected to tell.'
'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'
'Only when China treats India as an equal can we consider them real friends.'
'When there is unlocking, there is demand revival.' 'This is going to be the main growth engine in this kind of an economic scenario.'
'There are different kinds of risk.' 'It is a very powerful value. Your ability to de-risk the risk is also as important for risk taking.'
'When you sow a small plant, then you keep watch on it so that wild cattle should not eat that sapling.'
With India's imports exceeding exports, weak rupee does more harm than good. Analysts, however, say that rupee depriciation is positive for export-oriented sectors such as IT services, pharmaceuticals, textiles and automobiles
Indian drug maker Dr Reddy's Laboratories said on Friday its fiscal 2003 profit fell 28 per cent, on lower sales of a Prozac generic drug to the key US market and slowing domestic sales.\n\n\n\n
Glaxo wants to obtain trademark rights for 'Volmax', the brand name of its respiratory medicine.
In March, the FDA had issued an import alert, banning formulations and active pharmaceutical ingredients from the factory.
South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.
And the controversy continues!
The company's share price touched a 52-weeks high on Monday on speculation that the global drug major, Pfizer, may buy stake or strike a marketing deal with the company.
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
The test used now, called PCR (or polymerace chain reaction), uses a nasal or throat swab sample and identifies the virus. These tests take at least five hours to give results. The rapid test, on the other hand, uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein.
The Mumbai-based Piramal Healthcare is preparing to become the first private sector company to process opium for use in pharmaceutical products.
Sensex lost 184 points to trade at 23,878 and the Nifty has dropped 55 points to quote at 7,254.
This time food regulators found excess presence of ash content in Maggi
Lupin Pharmaceuticals has bought the US marketing rights of cholestrol-lowering drug Antara and related assets from bankrupt American entity Oscient Pharmaceuticals for $38.61 million
The government on Friday approved the acquisition of drug company Ranbaxy Laboratories by Japanese pharma major Daiichi Sankyo envisaging foreign investment of around Rs 21,500 crore (Rs 215 billion).
In containment areas, movements of people is totally banned and essential services are delivered at the doorsteps.
Dushyant has now emerged as a leader of some reckoning in the Jat community, as well among Haryana's youth.
Saudi Arabia is insisting on 'In Kingdom' total value-addition requirements
The medicines include tuberculosis drug moxifloxacin, antipsychotic olanzapine and valgancicloivir, a medicine often needed for HIV/AIDS patients. The groups allege that none of these drugs qualified the criteria specified under the Indian Patents Act and were given patent protection because the patent examiners overlooked the legal safeguards meant to avoid grant of patents to known substances or their mere improvements.
Drug maker Natco on Monday said that the Patent Office has upheld the firm's opposition to an application of Yeda Research & Development Company for patenting a generic version of a product of Teva Pharmaceutical Industries.
A large number of American companies like Google, Uber and IBM are offering their resources to help India successfully fight the battle against the deadly coronavirus pandemic.
A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.
The company did not respond to specific queries on the project's expansion.
In October 2007, Ranbaxy Laboratories picked up a 38 per cent additional stake in the company, taking its shareholding in the Hyderabad-based firm to 45 per cent. However, Ranbaxy had made it clear that it is not interested in taking over the company.
While there were no surprises on policy issues from either side, there were far less interruptions and tense moments between Pence, 61, who comes from Indiana and his Democrat challenger Harris, 55, who is from California.
Three stockmarket experts give their best picks for the New Year.
The Department of Industrial Policy and Promotion in its draft Cabinet has proposed to further tighten the rules for foreign direct investment in brownfield pharmaceutical sector.
Over the past few months, the two firms had been battling in courts over the price of the open offer. SAT's order regarding the status quo of the public offer came after Zenotech's two shareholders -- Jayaram Chigurupati and Narayan -- moved the tribunal against the Securities and Exchange Board of India's nod to Daiichi for the offer at Rs 113 a share.
The S&P BSE Sensex surged 217 points to end at 25,736.
Pharmaceutical giant GlaxoSmithKline has slashed prices of drugs for the poorest countries and is sharing part of the profits with these countries to beef up health facilities. CEO Andrew Witty said, ' We have the capacity to do more and we can do more. The question is can we, big pharmaceutical companies, rise to the challenge and be a genuine catalyst for change?'
'Tens of millions will be working from home for months at a time, which means the smartest brains in business will be focussed on creating more efficient WFH processes,' predicts Devangshu Datta.
The petition was dismissed by a Supreme Court bench headed by Justice A K Mathur. The Madhya Pradesh high court had earlier upheld a city court's decision to dismiss the state government's plea against the pharmaceutical firm. The petition filed in the apex court through counsel C D Singh stated that the High Court had failed to appreciate that the presence of foreign element in the medicine was a clear breach of provisions of the Durgs & Cosmetic Rules 1945.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances